Access to Care

NCCS is now Cancer Nation. Find out more about our next chapter. Join Us

Access to quality, affordable cancer care is essential for anyone with a cancer diagnosis. Access includes adequate health insurance that covers needed treatments without leaving people with cancer to suffer “financial toxicity.” People with cancer also need the ability to participate in a clinical trial, if it represents a potential treatment option.

Prior to the Affordable Care Act (ACA), cancer survivors were at the mercy of the health care system, often forced to pay exorbitant premiums or simply denied coverage altogether. Today, America’s 18.1 million cancer survivors benefit from the ACA’s patient protections that provide them with quality, affordable, and accessible health care coverage. Through the ACA, cancer patients and survivors can now purchase insurance through Healthcare.gov and state insurance exchanges. The ACA has afforded protections related to out-of-pocket expenses, lifetime caps, and pre-existing conditions.

Cancer Nation believes in the following principles for access to care:

Individuals with pre-existing conditions must not be denied coverage or charged higher premiums.
Plans must cover all essential health care needs.
Adequate financial assistance must be provided to ensure people with low and moderate incomes can purchase health insurance.
Insurers must not discriminate against older Americans, who are disproportionately impacted by cancer, or women.
Cost-sharing protections must be maintained, including caps on out-of-pocket costs and the elimination of annual and lifetime maximum benefits.
States should take advantage of the ACA’s Medicaid expansion, which provides coverage to low income individuals living with cancer.
People with pre-existing conditions must not be segregated into high-risk pools, which are expensive and burdensome and do not meet the needs of cancer patients.
Cancer patients must have access to comprehensive and well-coordinated cancer care, including clinical trials.

“For a cancer survivor, dealing with the collateral damage of cancer treatment and the continued surveillance for recurrence or secondary cancers, going without insurance is simply not an option. I am very worried that the proposed replacement for the ACA will harm cancer survivors, particularly people with low incomes and people over the age of 50. We simply can’t go back to the days before the ACA when cancer survivors could be denied coverage, and we must ensure people have access to quality, affordable health insurance.”

Michael Kappel, Cancer Nation board member and 13-year colon cancer survivor

Commuters are already moving about before dawn on the streets of Washington DC United States Capital City

Adobe Stock

National Patient Organizations United in Opposition to House Budget Resolution that Threatens Medicaid Coverage for Millions

February 24, 2025

The House of Representatives this week will consider a budget resolution instructing the House Energy and Commerce Committee to reduce…

A Voice for Change: Rebecca Muñoz’s AYA Cancer Journey of Advocacy and Research

February 12, 2025

Meet Rebecca Muñoz. Diagnosed with breast cancer at 29, she turned her challenges into advocacy, founding Chemotherapy Cold Cappers and working tirelessly to improve care for AYA cancer patients. From testifying for biomarker legislation to mentoring future cancer researchers, Rebecca’s advocacy is creating lasting change. Learn more about Rebecca in this month's Advocate Spotlight.

HHS Health Human Services Humphrey Building

NCCS Joins 28 Organizations Expressing Concern to Humana & CMS Over New Coverage Policy for Non-Small Cell Lung Cancer (NSCLC)

January 24, 2025

NCCS was one of twenty-eight organizations to sign patient community letters to Humana and the Centers for Medicare and Medicaid Services…

NCCS Endorses Health Care Affordability Act

January 24, 2025

Recently, NCCS endorsed the Health Care Affordability Act — bicameral legislation making permanent the Affordable Care Act’s (ACA)…

Advocate Spotlight Lou Lanza From Diagnosis to Determination: Lou Lanza's Commitment to Survivorship

From Diagnosis to Determination: Lou Lanza’s Commitment to Survivorship Advocacy

January 8, 2025

Meet Lou Lanza. After surviving Stage IIa Large B Cell Non-Hodgkin’s Lymphoma, Lou turned his journey into a mission to support survivors, caregivers, and the cancer community through tireless advocacy. Learn more about Lou in this month's Advocate Spotlight.